Alix Berglund

Conley, H., Till, R. L., Berglund, A. K., Jones, S. L., & Sheats, M. K. (2023). A myristoylated alanine-rich C-kinase substrate (MARCKS) inhibitor peptide attenuates neutrophil outside-in & beta;(2)-integrin activation and signaling. CELL ADHESION & MIGRATION, 17(1), 1–16. https://doi.org/10.1080/19336918.2023.2233204

Smith, H. L., Berglund, A. K., Robertson, J. B., Schnabel, L. V., McMullen, R. J., Jr, Gilger, B. C., & Oh, A. (2023). Effect of gentamicin on <scp>CD3</scp>+ T‐lymphocyte proliferation for treatment of equine recurrent uveitis: An in vitro study. Veterinary Ophthalmology, 26(4), 347–354. https://doi.org/10.1111/vop.13098

Koch, D. W. W., Berglund, A. K. K., Messenger, K. M. M., Gilbertie, J. M. M., Ellis, I. M. M., & Schnabel, L. V. V. (2022). Interleukin-1 beta in tendon injury enhances reparative gene and protein expression in mesenchymal stem cells. FRONTIERS IN VETERINARY SCIENCE, 9. https://doi.org/10.3389/fvets.2022.963759

Koch, D. W., Schnabel, L. V., Ellis, I. M., Bates, R. E., & Berglund, A. K. (2022). TGF-beta 2 enhances expression of equine bone marrow-derived mesenchymal stem cell paracrine factors with known associations to tendon healing. STEM CELL RESEARCH & THERAPY, 13(1). https://doi.org/10.1186/s13287-022-03172-9

Cameron, A. D., Even, K. M., Linardi, R. L., Berglund, A. K., Schnabel, L. V., Engiles, J. B., & Ortved, K. F. (2021). Adeno-Associated Virus-Mediated Overexpression of Interleukin-10 Affects the Immunomodulatory Properties of Equine Bone Marrow-Derived Mesenchymal Stem Cells. HUMAN GENE THERAPY, 32(17-18), 907–918. https://doi.org/10.1089/hum.2020.319

Rowland, A. L., Miller, D., Berglund, A., Schnabel, L. V., Levine, G. J., Antczak, D. F., & Watts, A. E. (2021). Cross-matching of allogeneic mesenchymal stromal cells eliminates recipient immune targeting. STEM CELLS TRANSLATIONAL MEDICINE, 10(5), 694–710. https://doi.org/10.1002/sctm.20-0435

Connard, S. S., Linardi, R. L., Even, K. M., Berglund, A. K., Schnabel, L. V., & Ortved, K. F. (2021, December). Effects of continuous passage on the immunomodulator properties of equine bone marrow-derived mesenchymal stem cells in vitro (vol 234, 110203, 2021). VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, Vol. 242. https://doi.org/10.1016/j.vetimm.2021.110340

Connard, S. S., Linardi, R. L., Even, K. M., Berglund, A. K., Schnabel, L. V., & Ortved, K. F. (2021). Effects of continuous passage on the immunomodulatory properties of equine bone marrow-derived mesenchymal stem cells in vitro. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 234. https://doi.org/10.1016/j.vetimm.2021.110203

Berglund, A. K., Long, J. M., Robertson, J. B., & Schnabel, L. V. (2021). TGF-beta 2 Reduces the Cell-Mediated Immunogenicity of Equine MHC-Mismatched Bone Marrow-Derived Mesenchymal Stem Cells Without Altering Immunomodulatory Properties. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 9. https://doi.org/10.3389/fcell.2021.628382

Gilbertie, J. M., Long, J. M., Schubert, A. G., Berglund, A. K., Schaer, T. P., & Schnabel, L. V. (2018). Pooled Platelet-Rich Plasma Lysate Therapy Increases Synoviocyte Proliferation and Hyaluronic Acid Production While Protecting Chondrocytes From Synoviocyte-Derived Inflammatory Mediators. FRONTIERS IN VETERINARY SCIENCE, 5. https://doi.org/10.3389/fvets.2018.00150

Berglund, A. K., & Schnabel, L. V. (2017). Allogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodies. EQUINE VETERINARY JOURNAL, 49(4), 539–544. https://doi.org/10.1111/evj.12647

Sherman, A. B., Gilger, B. C., Berglund, A. K., & Schnabel, L. V. (2017). Effect of bone marrow-derived mesenchymal stem cells and stem cell supernatant on equine corneal wound healing in vitro. Stem Cell Research & Therapy, 8(1). https://doi.org/10.1186/s13287-017-0577-3